...
首页> 外文期刊>Clinical cancer research: an official journal of the American Association for Cancer Research >Merkel Cell Carcinoma Patients Presenting Without a Primary Lesion Have Elevated Markers of Immunity, Higher Tumor Mutation Burden, and Improved Survival
【24h】

Merkel Cell Carcinoma Patients Presenting Without a Primary Lesion Have Elevated Markers of Immunity, Higher Tumor Mutation Burden, and Improved Survival

机译:没有初级病变的梅尔克尔细胞癌患者呈现较高的免疫标记,肿瘤突变负荷和改善的存活率

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: Patients presenting with nodal Merkel cell carcinoma without an identifiable (unknown) primary lesion (MCC-UP) are nearly twice as likely to survive compared with similarly staged patients with known primary lesions (MCC-KP). The basis of this previously reported finding is unclear.
机译:目的:与没有可识别的(未知)初级病变(MCC-Up)的患者患有Nodal Merkel细胞癌的患者与类似分阶段的初级病变(MCC-KP)相比存活的可能性几乎是存活的两倍。 此前报告的发现的基础尚不清楚。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号